194
Participants
Start Date
December 8, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
Rapid respiratory pathogen nucleic acid amplification test
Patients randomized to the rapid respiratory pathogen nucleic acid amplification test (Film Array Respiratory Panel, BioFire Diagnostics), will receive usual physician-directed care plus results from a rapid diagnostic test for 20 common respiratory pathogens. Patients will have a nasopharyngeal swab sample collected and tested during the ED episode of care with results reported in the electronic medical record (EMR) within two hours of sample collection. ED physicians will receive education regarding the rapid respiratory pathogen test prior to commencing the study. During the study, ED physicians will be free to review and interpret the respiratory pathogen test results and make treatment decisions based on their individual clinical judgment without involvement of study personnel.
UC Davis Medical Center, Sacramento
Collaborators (1)
BioFire Diagnostics, LLC
INDUSTRY
University of California, Davis
OTHER